Fibroin nanoparticles: a promising drug delivery system.
Fibroin
administrative route
biomaterial
nanoparticles
review
Journal
Drug delivery
ISSN: 1521-0464
Titre abrégé: Drug Deliv
Pays: England
ID NLM: 9417471
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
1
12
2020
Statut:
ppublish
Résumé
Fibroin is a dominant silk protein that possesses ideal properties as a biomaterial for drug delivery. Recently, the development of fibroin nanoparticles (FNPs) for various biomedical applications has been extensively studied. Due to their versatility and chemical modifiability, FNPs can encapsulate different types of therapeutic compounds, including small and big molecules, proteins, enzymes, vaccines, and genetic materials. Moreover, FNPs are able to be administered both parenterally and non-parenterally. This review summaries basic information on the silk and fibroin origin and characteristics, followed by the up-to-date data on the FNPs preparation and characterization methods. In addition, their medical applications as a drug delivery system are in-depth explored based on several administrative routes of parenteral, oral, transdermal, ocular, orthopedic, and respiratory. Finally, the challenges and suggested solutions, as well as the future outlooks of these systems are discussed.
Identifiants
pubmed: 32157919
doi: 10.1080/10717544.2020.1736208
pmc: PMC7144220
doi:
Substances chimiques
Biocompatible Materials
0
Silk
0
Fibroins
9007-76-5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
431-448Références
Toxics. 2017 Oct 17;5(4):
pubmed: 29051461
Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96
pubmed: 11311991
Int J Nanomedicine. 2009;4:115-22
pubmed: 19516890
ACS Biomater Sci Eng. 2018 Oct 8;4(10):3487-3497
pubmed: 33450797
Annu Rev Chem Biomol Eng. 2010;1:149-73
pubmed: 22432577
Biomaterials. 2006 Jun;27(16):3115-24
pubmed: 16458961
Biomaterials. 2003 Feb;24(3):401-16
pubmed: 12423595
Biochemistry. 2004 Sep 28;43(38):11932-41
pubmed: 15379533
Nanomedicine (Lond). 2010 Jul;5(5):807-20
pubmed: 20662650
J Agric Food Chem. 2011 Sep 28;59(18):10298-302
pubmed: 21846144
Eur J Pharm Biopharm. 2014 Sep;88(1):104-15
pubmed: 24833007
Int J Biol Macromol. 2013 Apr;55:88-97
pubmed: 23313451
Int J Nanomedicine. 2012;7:4545-57
pubmed: 22923992
Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:166-74
pubmed: 25280693
Int J Mol Sci. 2015 Mar 04;16(3):4880-903
pubmed: 25749470
Mater Sci Eng C Mater Biol Appl. 2014 Oct;43:231-6
pubmed: 25175209
Eur J Pharm Biopharm. 2015 Apr;91:82-90
pubmed: 25643990
Nat Protoc. 2011 Sep 22;6(10):1612-31
pubmed: 21959241
Biochem J. 1969 Oct;114(4):695-702
pubmed: 5343769
J Control Release. 2008 Nov 24;132(1):26-34
pubmed: 18761384
ACS Appl Mater Interfaces. 2013 Dec 11;5(23):12638-45
pubmed: 24274601
Expert Opin Drug Deliv. 2012 Sep;9(9):1161-76
pubmed: 22835210
Pharm Res. 2018 Nov 5;35(12):248
pubmed: 30397820
J Biomed Mater Res. 1999 Sep 5;46(3):382-9
pubmed: 10397996
Biomaterials. 2010 Feb;31(6):1025-35
pubmed: 19945157
Int J Nanomedicine. 2015 Dec 21;11:25-44
pubmed: 26730188
Anticancer Drugs. 1996 Jan;7(1):78-86
pubmed: 8742102
Front Chem. 2018 Jan 25;6:6
pubmed: 29473032
Acta Biomater. 2016 Jul 15;39:156-168
pubmed: 27181879
Toxicol Int. 2011 Jan;18(1):17-21
pubmed: 21430915
J Cell Physiol. 2017 Oct;232(10):2798-2805
pubmed: 27800612
Acta Biomater. 2018 Jun;73:355-364
pubmed: 29649640
Pharmaceutics. 2017 Nov 20;9(4):
pubmed: 29156634
Nat Mater. 2010 Apr;9(4):359-67
pubmed: 20228820
Int J Pharm. 2017 Feb 25;518(1-2):11-19
pubmed: 28012995
ACS Biomater Sci Eng. 2018 Aug 13;4(8):2836-2846
pubmed: 33435007
Biochem Biophys Res Commun. 1995 Mar 17;208(2):511-6
pubmed: 7695601
Br J Clin Pharmacol. 2003 Dec;56(6):588-99
pubmed: 14616418
ACS Biomater Sci Eng. 2018 Nov 12;4(11):3885-3894
pubmed: 33429597
Nature. 2003 Aug 28;424(6952):1057-61
pubmed: 12944968
Nanomedicine (Lond). 2017 Mar;12(6):683-702
pubmed: 28186436
Int J Mol Sci. 2009 Mar 31;10(4):1514-24
pubmed: 19468322
Nanomedicine (Lond). 2016 Mar;11(6):673-92
pubmed: 27003448
Int J Biol Macromol. 1999 Mar-Apr;24(2-3):237-42
pubmed: 10342770
ACS Biomater Sci Eng. 2018 Mar 12;4(3):942-951
pubmed: 33418776
Int J Nanomedicine. 2016 Sep 02;11:4373-80
pubmed: 27621628
Appl Biochem Biotechnol. 2014 May;173(2):544-51
pubmed: 24671567
Adv Biochem Eng Biotechnol. 2006;102:47-90
pubmed: 17089786
Int J Ophthalmol. 2018 Jun 18;11(6):1038-1044
pubmed: 29977820
Int J Biol Macromol. 2015 Nov;81:317-31
pubmed: 26277745
Colloids Surf B Biointerfaces. 2019 Sep 1;181:705-713
pubmed: 31228853
Macromol Biosci. 2015 May;15(5):719-27
pubmed: 25644632
Int J Pharm. 2019 Jan 30;555:322-336
pubmed: 30448314
Biotechnol Bioeng. 2008 Apr 15;99(6):1482-9
pubmed: 17969177
J Pharm Sci. 2006 Jul;95(7):1626-39
pubmed: 16729268
PLoS One. 2016 Dec 12;11(12):e0168042
pubmed: 27941996
Int J Pharm. 2008 Feb 28;350(1-2):14-26
pubmed: 18162341
Colloids Surf B Biointerfaces. 2015 Dec 1;136:867-77
pubmed: 26547314
Int J Mol Sci. 2017 Mar 03;18(3):
pubmed: 28273799
Colloids Surf B Biointerfaces. 2019 Mar 1;175:564-568
pubmed: 30579057
J Phys Chem B. 2006 Nov 2;110(43):21630-8
pubmed: 17064118
Pharm Dev Technol. 2019 Jun;24(5):575-583
pubmed: 30457420
Sci Rep. 2015 Aug 03;5:11878
pubmed: 26234773
ISRN Pharm. 2014 Apr 09;2014:926157
pubmed: 25101184
J Drug Target. 2019 Apr;27(4):379-393
pubmed: 30103626
Colloids Surf B Biointerfaces. 2017 Dec 1;160:704-714
pubmed: 29035818
ACS Appl Mater Interfaces. 2017 Feb 15;9(6):5128-5138
pubmed: 28106379
J Control Release. 2015 May 28;206:161-76
pubmed: 25797561
Biomed Mater. 2014 Jun;9(3):035015
pubmed: 24867887
J Control Release. 2001 Jan 29;70(1-2):1-20
pubmed: 11166403
Drug Deliv Transl Res. 2020 Apr;10(2):413-424
pubmed: 31701488
Int J Biol Macromol. 2010 Jun;46(5):493-501
pubmed: 20338193
Nat Rev Cancer. 2008 Jun;8(6):473-80
pubmed: 18469827
Adv Drug Deliv Rev. 2010 Dec 30;62(15):1497-508
pubmed: 20298729
Antimicrob Agents Chemother. 2002 Mar;46(3):834-40
pubmed: 11850269
Int J Pharm. 2010 Mar 30;388(1-2):242-50
pubmed: 20060449
Nanomedicine. 2013 Jan;9(1):1-14
pubmed: 22684017
Int J Pharm. 2005 Mar 23;292(1-2):95-117
pubmed: 15725557
Acta Biomater. 2016 Feb;31:1-16
pubmed: 26360593
Biomaterials. 2008 Aug-Sep;29(24-25):3415-28
pubmed: 18502501
Int J Nanomedicine. 2014 Sep 23;9:4507-20
pubmed: 25285004
J Biomed Nanotechnol. 2019 Apr 1;15(4):769-778
pubmed: 30841969
ACS Appl Mater Interfaces. 2015 Sep 30;7(38):21254-62
pubmed: 26331584
Proteins. 2001 Aug 1;44(2):119-22
pubmed: 11391774
Crit Rev Ther Drug Carrier Syst. 2002;19(2):99-134
pubmed: 12197610
Macromol Biosci. 2006 Apr 12;6(4):285-92
pubmed: 16572474
J Control Release. 2016 Sep 28;238:176-185
pubmed: 27480450
Soft Matter. 2007 Jun 19;3(7):910-915
pubmed: 32900086
Biomaterials. 2010 Jun;31(16):4583-91
pubmed: 20219241
Int J Nanomedicine. 2017 Oct 20;12:7751-7761
pubmed: 29118580
Int J Pharm. 2013 Sep 15;454(1):216-25
pubmed: 23856159
J Control Release. 2011 Mar 10;150(2):128-41
pubmed: 21059377
Eur J Biochem. 1999 Jan;259(1-2):120-6
pubmed: 9914483
J AOAC Int. 2010 Jul-Aug;93(4):1143-7
pubmed: 20922945
Biomacromolecules. 2013 Dec 9;14(12):4465-74
pubmed: 24224461
Biomed Eng Online. 2013 Apr 08;12:28
pubmed: 23566031
Adv Mater. 2014 Nov 19;26(43):7393-8
pubmed: 25238148
Biomacromolecules. 2015 Feb 9;16(2):606-14
pubmed: 25565556
J Control Release. 2016 Oct 28;240:504-526
pubmed: 27292178
Adv Healthc Mater. 2019 Jan;8(1):e1800465
pubmed: 30238637
Sheng Wu Gong Cheng Xue Bao. 2014 Mar;30(3):393-403
pubmed: 25007575
Biomaterials. 2019 Aug;212:39-54
pubmed: 31103945
Biomaterials. 2010 Apr;31(10):2926-33
pubmed: 20044136
Int J Biol Macromol. 2006 May 30;38(3-5):284-8
pubmed: 16678253
Nanoscale. 2017 Aug 17;9(32):11739-11753
pubmed: 28782773
Regul Toxicol Pharmacol. 2015 Jul;72(2):310-22
pubmed: 25979643